Ad hoc Announcements

Listed companies are obliged by law to publish without delay news of all company occurences that could influence the share price significantly (section 15 of the German Securities Trading Act).
 
 
DateTitleDownload 
02/28/2010Merck KGaA to Acquire Millipore – Creating a World-Class Partner for the Life Science Sectorpdf (15 kb)
DateTitleDownload 
11/30/2009Merck KGaA Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Applicationpdf (12 kb)
07/23/2009Merck KGaA receives CHMP Opinion on Erbitux for Lung Cancerpdf (12 kb)
No ad-hoc announcements were published in 2008.

DateTitleDownload 
09/11/2007Merck: Erbitux Phase III Study – FLEX Increases Overall Survival in
First-line Treatment of Non-Small Cell Lung Cancer
pdf (7 kb)
05/13/2007Merck KGaA: Merck Sells Generics Business to Mylan for EUR 4.9 Billionpdf (12 kb)
02/21/2007Merck KGaA: Karl-Ludwig Kley to Succeed Michael Roemer as Chairman of the Executive Boardpdf (11 kb)
DateTitleDownload 
09/21/2006Merck KGaA acquires majority stake in Serono SALink
06/23/2006Merck KGaA: Development of Sarizotan to treat Parkinson’s patients will not be pursuedpdf (10 kb)
06/14/2006Merck KGaA: Merck To Transfer Its Schering Shares to Bayerpdf (69 kb)
03/24/2006Merck KGaA Will Not Increase Its Offer for Schering AGpdf (15 kb)
03/13/2006Merck KGaA Announces Takeover Offer for Schering AGpdf (70 kb)
03/13/2006Announcement pursuant to Section 10 of the German Securities Acquisition and Takeover Actpdf (37 kb)
11/22/2005Merck KGaA Announces New Leadershippdf (40 kb)
09/29/2005Merck KGaA and Takeda to Co-Develop and Co-Promote Matuzumab Cancer Treatmentpdf (12 kb)
02/08/2005Merck KGaA Acquires Avecia’s OLED and Polymer Electronics Unitspdf (12 kb)
DateTitleDownload 
11/02/2004Merck KGaA Considers Potential Divestment of Electronic Chemicals Businesspdf (11 kb)
02/16/2004Merck KGaA to Sell VWR International to Clayton, Dubilier & Rice, Inc.pdf (11 kb)